Accelerating Innovations in Life Sciences and Healthcare
Biotech, Diagnostics, Medical devices, Pharma, Digital health
OUR LIFE SCIENCES & HEALTHCARE PRACTICE
16% DIGITAL HEALTH
28% MEDICAL DEVICES
Larta propels cutting-edge life sciences and healthcare technologies to marketplace success. One testament to the effectiveness of Larta’s award-winning model: For 15 years in a row, we have been selected by the NIH to design and deliver the Commercialization Accelerator Program for SBIR Phase II awardees.
“Larta continually pulls out all the stops and evolves their programs for year to year, staying on top of current trends. Larta is a thought-leader at the nexus of innovation and commercialization.”
– Matthew E. Portnoy, Ph.D., Deputy Director, Division of Extramural Activities, NIDDK/NIH
THE HEAL PROGRAM
The Heal Program is a new commercialization program for emerging bioscience startups in the Greater Los Angeles Area to accelerate their market and investor readiness. A collaboration between Larta Institute, The Lundquist Institute, and BioLabs LA, Heal will provide early stage companies with a custom road-map, a world-class team of domain experts, a dedicated mentor, and access to customers and stakeholders across our collective networks.
FUNDING RAISED BY COMPANIES
LARTA’S SYSTEM SPEEDS THE PATH FROM IDEA TO COMMERCIAL SUCCESS
Our network-centric approach and proven methodology is the fast track from science-based innovation to commercial relevance. From ideation to growth to scale, we work with technology entrepreneurs to navigate critical tech-to-market issues, develop actionable plans, and connect them with potential investors, partners and customers.
Companies can take advantage of Larta’s full menu of services at any stage from inception to scale-up.
PARTNERS IN THE ADVANCEMENT OF CUTTING-EDGE INNOVATION
Larta partners with organizations and governments worldwide to develop pathways for science-based innovators to build and grow their businesses. In addition to our work with the NIH, we have implemented successful commercialization assistance programs (CAP) with organizations such as The Lundquist Institute (“Transforming Today’s Research into Tomorrow’s Cures”) and The Iowa Economic Development Council.
Companies are in sectors such as medical devices, biotech, pharmaceuticals, healthcare IT and diagnostics.
IrisVision: Wearable breakthrough that allows people with low vision to see clearly again
Having participated in Larta’s NIH CAP program, IrisVison is achieving market traction both through vision care professionals and direct sales to the consumer.
Bivacor: An artificial heart designed to take over the complete function of a patient’s failing heart
Collaboration with NASA will further support medical industry assessments and provide insights on safety and reliability.